Theranostic designs of biomaterials for precision medicine in cancer therapy

Hyosuk Kim, Gijung Kwak, Kwang Meyung Kim, Hong Yeol Yoon, Ick Chan Kwon

Research output: Contribution to journalReview article

Abstract

Theranostic biomaterials have been creating great new opportunities in developing precision medicine in cancer treatment. Moreover, there exist up-coming potentials to find a new paradigm change in cancer treatment when theranostic biomaterials can precisely image a biological process at the exact tumor sites. With aid of molecular imaging technology, theranostic biomaterials can visualize targets, monitor efficiency of delivery carriers as well as therapeutic responses at tumor site. Major obstacles in designing theranostic biomaterials might be what providing target-specificity to biomaterials for improving therapeutic efficacy as well as visualization in cancer treatment. By which, we can find ways to minimize unwanted side effects to normal tissues in cancer therapy. This review focuses on how theranostic biomaterials can be designed with tumor-specific fluorescence imaging probes, especially tumor-specific activatable imaging probes, which in turn can be switched to therapeutic design with identical principle. Highlights such as designing by characteristics of cancer, finding ways to monitor therapeutic efficacy, potential benefits in theranostic biomaterials are also discussed.

Original languageEnglish
Article number119207
JournalBiomaterials
Volume213
DOIs
Publication statusPublished - 2019 Aug 1

Fingerprint

Precision Medicine
Biocompatible Materials
Biomaterials
Medicine
Oncology
Tumors
Neoplasms
Therapeutics
Molecular imaging
Imaging techniques
Biological Phenomena
Theranostic Nanomedicine
Molecular Imaging
Optical Imaging
Visualization
Fluorescence
Tissue
Technology

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Theranostic designs of biomaterials for precision medicine in cancer therapy. / Kim, Hyosuk; Kwak, Gijung; Kim, Kwang Meyung; Yoon, Hong Yeol; Kwon, Ick Chan.

In: Biomaterials, Vol. 213, 119207, 01.08.2019.

Research output: Contribution to journalReview article

Kim, Hyosuk ; Kwak, Gijung ; Kim, Kwang Meyung ; Yoon, Hong Yeol ; Kwon, Ick Chan. / Theranostic designs of biomaterials for precision medicine in cancer therapy. In: Biomaterials. 2019 ; Vol. 213.
@article{28fb90c1d7a848669908eb6241d4a558,
title = "Theranostic designs of biomaterials for precision medicine in cancer therapy",
abstract = "Theranostic biomaterials have been creating great new opportunities in developing precision medicine in cancer treatment. Moreover, there exist up-coming potentials to find a new paradigm change in cancer treatment when theranostic biomaterials can precisely image a biological process at the exact tumor sites. With aid of molecular imaging technology, theranostic biomaterials can visualize targets, monitor efficiency of delivery carriers as well as therapeutic responses at tumor site. Major obstacles in designing theranostic biomaterials might be what providing target-specificity to biomaterials for improving therapeutic efficacy as well as visualization in cancer treatment. By which, we can find ways to minimize unwanted side effects to normal tissues in cancer therapy. This review focuses on how theranostic biomaterials can be designed with tumor-specific fluorescence imaging probes, especially tumor-specific activatable imaging probes, which in turn can be switched to therapeutic design with identical principle. Highlights such as designing by characteristics of cancer, finding ways to monitor therapeutic efficacy, potential benefits in theranostic biomaterials are also discussed.",
author = "Hyosuk Kim and Gijung Kwak and Kim, {Kwang Meyung} and Yoon, {Hong Yeol} and Kwon, {Ick Chan}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.biomaterials.2019.05.018",
language = "English",
volume = "213",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Theranostic designs of biomaterials for precision medicine in cancer therapy

AU - Kim, Hyosuk

AU - Kwak, Gijung

AU - Kim, Kwang Meyung

AU - Yoon, Hong Yeol

AU - Kwon, Ick Chan

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Theranostic biomaterials have been creating great new opportunities in developing precision medicine in cancer treatment. Moreover, there exist up-coming potentials to find a new paradigm change in cancer treatment when theranostic biomaterials can precisely image a biological process at the exact tumor sites. With aid of molecular imaging technology, theranostic biomaterials can visualize targets, monitor efficiency of delivery carriers as well as therapeutic responses at tumor site. Major obstacles in designing theranostic biomaterials might be what providing target-specificity to biomaterials for improving therapeutic efficacy as well as visualization in cancer treatment. By which, we can find ways to minimize unwanted side effects to normal tissues in cancer therapy. This review focuses on how theranostic biomaterials can be designed with tumor-specific fluorescence imaging probes, especially tumor-specific activatable imaging probes, which in turn can be switched to therapeutic design with identical principle. Highlights such as designing by characteristics of cancer, finding ways to monitor therapeutic efficacy, potential benefits in theranostic biomaterials are also discussed.

AB - Theranostic biomaterials have been creating great new opportunities in developing precision medicine in cancer treatment. Moreover, there exist up-coming potentials to find a new paradigm change in cancer treatment when theranostic biomaterials can precisely image a biological process at the exact tumor sites. With aid of molecular imaging technology, theranostic biomaterials can visualize targets, monitor efficiency of delivery carriers as well as therapeutic responses at tumor site. Major obstacles in designing theranostic biomaterials might be what providing target-specificity to biomaterials for improving therapeutic efficacy as well as visualization in cancer treatment. By which, we can find ways to minimize unwanted side effects to normal tissues in cancer therapy. This review focuses on how theranostic biomaterials can be designed with tumor-specific fluorescence imaging probes, especially tumor-specific activatable imaging probes, which in turn can be switched to therapeutic design with identical principle. Highlights such as designing by characteristics of cancer, finding ways to monitor therapeutic efficacy, potential benefits in theranostic biomaterials are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=85066424795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066424795&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2019.05.018

DO - 10.1016/j.biomaterials.2019.05.018

M3 - Review article

C2 - 31136910

AN - SCOPUS:85066424795

VL - 213

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

M1 - 119207

ER -